Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

The discordance between extremely high seroprevalence of Taenia solium antibodies in disease-endemic populations, relatively few symptomatic cases of neurocysticercosis, and high background levels of putatively inactive brain lesions (mainly calcifications) in seronegative controls have confused researchers, clinicians, and epidemiologists in the last decade. We reviewed longitudinal serologic data from general population serosurveys in 3 different disease-endemic areas of Peru and Colombia and found that approximately 40% of seropositive people were seronegative when resampled after 1 year (3 surveys) or after 3 years (1 survey). Transient antibodies may have significant implications for the epidemiology of and immunity to this disease.

[1]  C. Evans,et al.  Magnitude of the disease burden from neurocysticercosis in a developing country. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Preux,et al.  Epilepsy and neurocysticercosis in an Andean community. , 1999, International journal of epidemiology.

[3]  M. T. Medina,et al.  A population-based, case-control study of Taenia solium taeniasis and cysticercosis , 1999, Annals of Tropical Medicine And Parasitology.

[4]  A. White,et al.  Neurocysticercosis: a major cause of neurological disease worldwide. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  P. Craig,et al.  Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. , 1996, The American journal of tropical medicine and hygiene.

[6]  V. Tsang,et al.  Taenia solium cysticercosis: An under-recognized but serious publica health problem , 1995 .

[7]  A. Flisser,et al.  Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  R. Gilman,et al.  Cysticercosis as a major cause of epilepsy in Peru , 1993, The Lancet.

[9]  J. A. Brand,et al.  An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). , 1989, The Journal of infectious diseases.